首页> 外国专利> Pyridyl- and pyrimidyl-piperazines for the treatment of substance abuse diseases

Pyridyl- and pyrimidyl-piperazines for the treatment of substance abuse diseases

机译:吡啶基和嘧啶基哌嗪类药物治疗药物滥用疾病

摘要

PURPOSE: Compounds of formula(1) represent a novel class of psychotropic agents by having high affinity for both 5-HT1A and 5-HT2 receptors and low to moderate 5-HT re-uptake inhibiting properties. CONSTITUTION: Formula(1); wherein R1 represents either halogen or hydrogen, R2 represents halogen, X is CH2, O, or S, R3 and R4 are the same or different and selected from hydrogen or lower alkyl, n is 2 or 3, and A is selected from the pyrimidyl- or pyridyl- groups; is useful for the manufacture of a medicament for the relief or prevention of a withdrawal syndrome resulting from addition to a drug or substance of abuse or for treatment thereof.
机译:目的:式(1)的化合物通过对5-HT1A和5-HT2受体都具有高亲和力和低至中等的5-HT再摄取抑制特性,代表了一类新型的精神药物。组成:公式(1);其中R1代表卤素或氢,R2代表卤素,X是CH2,O或S,R3和R4相同或不同,并且选自氢或低级烷基,n是2或3,并且A选自嘧啶基-或吡啶基-基团;可用于制造用于减轻或预防由于添加到滥用的药物或物质中而引起的戒断综合症的药物或用于其治疗的药物。

著录项

  • 公开/公告号KR100491027B1

    专利类型

  • 公开/公告日2005-09-30

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR19980708781

  • 发明设计人 브죄르크 앤더스;

    申请日1998-10-30

  • 分类号A61K31/495;A61K31/505;

  • 国家 KR

  • 入库时间 2022-08-21 22:03:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号